{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,26]],"date-time":"2025-06-26T04:06:45Z","timestamp":1750910805541,"version":"3.41.0"},"reference-count":51,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","surgonc.theclinics.com","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Surgical Oncology Clinics of North America"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.soc.2024.11.001","type":"journal-article","created":{"date-parts":[[2024,11,28]],"date-time":"2024-11-28T20:41:36Z","timestamp":1732826496000},"page":"211-226","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Treatment and Management of Peritoneal Spread from Colorectal Cancer Peritoneal Metastasis"],"prefix":"10.1016","volume":"34","author":[{"given":"Gregor","family":"Werba","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melanie","family":"Ongchin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.soc.2024.11.001_bib1","doi-asserted-by":"crossref","DOI":"10.3322\/caac.21772","article-title":"Colorectal cancer statistics, 2023","volume":"73","author":"Siegel","year":"2023","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.soc.2024.11.001_bib2","article-title":"Colorectal cancer in the young: epidemiology, prevention, management","volume":"40","author":"Siegel","year":"2020","journal-title":"Am Soc Clin Oncol Educ Book"},{"author":"Jayne","key":"10.1016\/j.soc.2024.11.001_bib3"},{"issue":"8","key":"10.1016\/j.soc.2024.11.001_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejso.2013.10.001","article-title":"Metachronous peritoneal carcinomatosis after curative treatment of colorectal cancer","volume":"40","author":"Van Gestel","year":"2014","journal-title":"Eur J Surg Oncol"},{"issue":"1","key":"10.1016\/j.soc.2024.11.001_bib5","doi-asserted-by":"crossref","DOI":"10.1038\/s41572-021-00326-6","article-title":"Primary and metastatic peritoneal surface malignancies","volume":"7","author":"Cort\u00e9s-Guiral","year":"2021","journal-title":"Nat Rev Dis Primers"},{"issue":"12","key":"10.1016\/j.soc.2024.11.001_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/S1470-2045(16)30500-9","article-title":"Prognosis of patients with peritoneal metastatic colorectal cancer given systemic therapy: an analysis of individual patient data from prospective randomised trials from the Analysis and Research in Cancers of the Digestive System (ARCAD) database","volume":"17","author":"Franko","year":"2016","journal-title":"Lancet Oncol"},{"issue":"11","key":"10.1016\/j.soc.2024.11.001_bib7","doi-asserted-by":"crossref","DOI":"10.1038\/s41571-022-00675-5","article-title":"Advances in the management of peritoneal malignancies","volume":"19","author":"Kepenekian","year":"2022","journal-title":"Nat Rev Clin Oncol"},{"issue":"2","key":"10.1016\/j.soc.2024.11.001_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/S1470-2045(20)30599-4","article-title":"Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy versus cytoreductive surgery alone for colorectal peritoneal metastases (PRODIGE 7): a multicentre, randomised, open-label, phase 3 trial","volume":"22","author":"Qu\u00e9net","year":"2021","journal-title":"Lancet Oncol"},{"issue":"20","key":"10.1016\/j.soc.2024.11.001_bib9","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2003.04.187","article-title":"Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer","volume":"21","author":"Verwaal","year":"2003","journal-title":"J\u00a0Clin Oncol"},{"issue":"7","key":"10.1016\/j.soc.2024.11.001_bib10","doi-asserted-by":"crossref","DOI":"10.1001\/jamasurg.2023.0662","article-title":"Efficacy and safety of intraoperative hyperthermic intraperitoneal chemotherapy for locally advanced colon cancer: a phase 3 randomized clinical trial","volume":"158","author":"Arjona-S\u00e1nchez","year":"2023","journal-title":"JAMA Surg"},{"issue":"1","key":"10.1016\/j.soc.2024.11.001_bib11","doi-asserted-by":"crossref","DOI":"10.1186\/s12885-015-1430-7","article-title":"Adjuvant hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with colon cancer at high risk of peritoneal carcinomatosis; the COLOPEC randomized multicentre trial","volume":"15","author":"Klaver","year":"2015","journal-title":"BMC Cancer"},{"issue":"2","key":"10.1016\/j.soc.2024.11.001_bib12","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.22.02644","article-title":"Adjuvant hyperthermic intraperitoneal chemotherapy in patients with locally advanced colon cancer (COLOPEC): 5-year results of a randomized multicenter trial","volume":"42","author":"Zwanenburg","year":"2024","journal-title":"J\u00a0Clin Oncol"},{"issue":"9","key":"10.1016\/j.soc.2024.11.001_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/S1470-2045(20)30322-3","article-title":"Second-look surgery plus hyperthermic intraperitoneal chemotherapy versus surveillance in patients at high risk of developing colorectal peritoneal metastases (PROPHYLOCHIP\u2013PRODIGE 15): a randomised, phase 3 study","volume":"21","author":"Go\u00e9r\u00e9","year":"2020","journal-title":"Lancet Oncol"},{"issue":"3","key":"10.1016\/j.soc.2024.11.001_bib14","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2011.37.1039","article-title":"Treatment of colorectal peritoneal carcinomatosis with systemic chemotherapy: a pooled analysis of North Central Cancer Treatment Group phase III trials N9741 and N9841","volume":"30","author":"Franko","year":"2012","journal-title":"J\u00a0Clin Oncol"},{"issue":"3","key":"10.1016\/j.soc.2024.11.001_bib15","doi-asserted-by":"crossref","DOI":"10.1245\/s10434-007-9701-4","article-title":"Aggressive surgical management of peritoneal carcinomatosis with low mortality in a high-volume Tertiary Cancer Center","volume":"15","author":"Gusani","year":"2008","journal-title":"Ann Surg Oncol"},{"issue":"13","key":"10.1016\/j.soc.2024.11.001_bib16","doi-asserted-by":"crossref","DOI":"10.1245\/s10434-011-1793-1","article-title":"Survival and quality of life following cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis of colonic origin","volume":"18","author":"Hill","year":"2011","journal-title":"Ann Surg Oncol"},{"issue":"6","key":"10.1016\/j.soc.2024.11.001_bib17","doi-asserted-by":"crossref","DOI":"10.1097\/SLA.0b013e31827e9289","article-title":"Is there a possibility of a cure in patients with colorectal peritoneal carcinomatosis amenable to complete cytoreductive surgery and intraperitoneal chemotherapy?","volume":"257","author":"Go\u00e9r\u00e9","year":"2013","journal-title":"Ann Surg"},{"issue":"1","key":"10.1016\/j.soc.2024.11.001_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejso.2022.07.019","article-title":"Patterns and timing of recurrence following CRS and HIPEC in colorectal cancer peritoneal metastasis","volume":"49","author":"Hassan","year":"2023","journal-title":"Eur J Surg Oncol"},{"issue":"39","key":"10.1016\/j.soc.2024.11.001_bib19","doi-asserted-by":"crossref","DOI":"10.3748\/wjg.v18.i39.5489","article-title":"Peritoneal carcinomatosis of colorectal origin: incidence, prognosis and treatment options","volume":"18","author":"Klaver","year":"2012","journal-title":"World J Gastroenterol"},{"issue":"1","key":"10.1016\/j.soc.2024.11.001_bib20","doi-asserted-by":"crossref","DOI":"10.1007\/s11547-016-0682-x","article-title":"Diagnostic performance of computed tomography and magnetic resonance imaging for detecting peritoneal metastases: systematic review and meta-analysis","volume":"122","author":"Laghi","year":"2017","journal-title":"Radiologia Medica"},{"issue":"6","key":"10.1016\/j.soc.2024.11.001_bib21","doi-asserted-by":"crossref","DOI":"10.1002\/jso.21601","article-title":"Accuracy and clinical relevance of computed tomography scan interpretation of peritoneal cancer index in colorectal cancer peritoneal carcinomatosis: a multi-institutional study","volume":"102","author":"Esquivel","year":"2010","journal-title":"J\u00a0Surg Oncol"},{"issue":"3","key":"10.1016\/j.soc.2024.11.001_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/S1055-3207(03)00048-6","article-title":"Peritonectomy procedures","volume":"12","author":"Sugarbaker","year":"2003","journal-title":"Surg Oncol Clin N Am"},{"issue":"1","key":"10.1016\/j.soc.2024.11.001_bib23","doi-asserted-by":"crossref","DOI":"10.1002\/jso.21169","article-title":"Evaluation of a peritoneal surface disease severity score in patients with colon cancer with peritoneal carcinomatosis","volume":"99","author":"Pelz","year":"2009","journal-title":"J\u00a0Surg Oncol"},{"issue":"13","key":"10.1016\/j.soc.2024.11.001_bib24","doi-asserted-by":"crossref","DOI":"10.1245\/s10434-016-5211-6","article-title":"Development of a prognostic nomogram for patients with peritoneally metastasized colorectal cancer treated with cytoreductive surgery and HIPEC","volume":"23","author":"Simkens","year":"2016","journal-title":"Ann Surg Oncol"},{"issue":"5","key":"10.1016\/j.soc.2024.11.001_bib25","doi-asserted-by":"crossref","DOI":"10.1245\/s10434-015-4958-5","article-title":"Laparoscopy is safe and accurate to evaluate peritoneal surface metastasis prior to cytoreductive surgery","volume":"23","author":"Marmor","year":"2016","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"10.1016\/j.soc.2024.11.001_bib26","article-title":"Role pf explorative laparoscopy to evaluate optimal candidates for cytoreductive surgery and hyperthermic intraperitioneal chemotherapy (HIPEC) in patients with peritoneal mesothelioma","volume":"23","author":"Laterza","year":"2009","journal-title":"In\u00a0Vivo (Brooklyn)"},{"issue":"8","key":"10.1016\/j.soc.2024.11.001_bib27","doi-asserted-by":"crossref","DOI":"10.1002\/jso.23597","article-title":"Patterns of recurrence following complete cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer","volume":"109","author":"Braam","year":"2014","journal-title":"J\u00a0Surg Oncol"},{"issue":"8","key":"10.1016\/j.soc.2024.11.001_bib28","doi-asserted-by":"crossref","DOI":"10.1001\/jamasurg.2021.1642","article-title":"Perioperative systemic therapy vs cytoreductive surgery and hyperthermic intraperitoneal chemotherapy alone for resectable colorectal peritoneal metastases: a phase 2 randomized clinical trial","volume":"156","author":"Rovers","year":"2021","journal-title":"JAMA Surg"},{"key":"10.1016\/j.soc.2024.11.001_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2022.101746","article-title":"Perioperative chemotherapy in colorectal cancer with peritoneal metastases: a global propensity score matched study","volume":"55","author":"Cashin","year":"2023","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.soc.2024.11.001_bib30","doi-asserted-by":"crossref","DOI":"10.1093\/annonc\/mdz155.369","article-title":"Role of radiotherapy in local control of metastatic rectal cancer: a single-center experience","volume":"30","author":"Afonso","year":"2019","journal-title":"Ann Oncol"},{"issue":"5","key":"10.1016\/j.soc.2024.11.001_bib31","doi-asserted-by":"crossref","DOI":"10.1002\/jso.27370","article-title":"Prognostic indicators for colorectal peritoneal metastases are different for patients with complete versus incomplete cytoreductive surgery","volume":"128","author":"Ghabra","year":"2023","journal-title":"J\u00a0Surg Oncol"},{"issue":"1","key":"10.1016\/j.soc.2024.11.001_bib32","article-title":"Peritoneal colorectal carcinomatosis treated with surgery and perioperative intraperitoneal chemotherapy: retrospective analysis of 523 patients from a multicentric French study","volume":"28","year":"2010","journal-title":"J\u00a0Clin Oncol"},{"issue":"1","key":"10.1016\/j.soc.2024.11.001_bib33","doi-asserted-by":"crossref","DOI":"10.1245\/s10434-015-4627-8","article-title":"Linear relationship of peritoneal cancer index and survival in patients with peritoneal metastases from colorectal cancer","volume":"23","author":"Faron","year":"2016","journal-title":"Ann Surg Oncol"},{"issue":"9","key":"10.1016\/j.soc.2024.11.001_bib34","doi-asserted-by":"crossref","DOI":"10.1245\/s10434-015-4387-5","article-title":"Extent of colorectal peritoneal carcinomatosis: attempt to define a threshold above which HIPEC does not offer survival benefit: a comparative study","volume":"22","author":"Go\u00e9r\u00e9","year":"2015","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.soc.2024.11.001_bib35","doi-asserted-by":"crossref","DOI":"10.3389\/fsurg.2022.1006591","article-title":"Synchronous liver and peritoneal metastases from colorectal cancer: is cytoreductive surgery and hyperthermic intraperitoneal chemotherapy combined with liver resection a feasible option?","volume":"9","author":"Di Carlo","year":"2022","journal-title":"Front Surg"},{"issue":"4","key":"10.1016\/j.soc.2024.11.001_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejso.2004.01.017","article-title":"The management of synchronous peritoneal carcinomatosis and hematogenous metastasis from colorectal cancer","volume":"30","author":"Carmignani","year":"2004","journal-title":"Eur J Surg Oncol"},{"issue":"3","key":"10.1016\/j.soc.2024.11.001_bib37","article-title":"Outcomes of combined peritoneal and local treatment for patients with peritoneal and limited liver metastases of colorectal origin: a systematic review and meta-analysis","volume":"29","author":"Polderdijk","year":"2022","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.soc.2024.11.001_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.jss.2017.05.126","article-title":"Safety and efficacy of combined resection of colorectal peritoneal and liver metastases","volume":"219","author":"Downs-Canner","year":"2017","journal-title":"J\u00a0Surg Res"},{"issue":"11","key":"10.1016\/j.soc.2024.11.001_bib39","article-title":"The Chicago Consensus on peritoneal surface malignancies: management of colorectal metastases","volume":"126","author":"Izquierdo","year":"2020","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.soc.2024.11.001_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejso.2020.09.017","article-title":"Colorectal cancer cells from patients treated with FOLFOX or CAPOX are resistant to oxaliplatin","volume":"47","author":"Nagourney","year":"2021","journal-title":"Eur J Surg Oncol"},{"issue":"2","key":"10.1016\/j.soc.2024.11.001_bib41","doi-asserted-by":"crossref","DOI":"10.1093\/bjsopen\/zraa075","article-title":"Effect of oxaliplatin-based chemotherapy on chemosensitivity in patients with peritoneal metastasis from colorectal cancer treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: proof-of-concept study","volume":"5","author":"Prabhu","year":"2021","journal-title":"BJS Open"},{"issue":"7","key":"10.1016\/j.soc.2024.11.001_bib42","doi-asserted-by":"crossref","DOI":"10.1002\/jso.23728","article-title":"The American Society of Peritoneal Surface Malignancies evaluation of HIPEC with Mitomycin C versus Oxaliplatin in 539 patients with colon cancer undergoing a complete cytoreductive surgery","volume":"110","author":"Prada-Villaverde","year":"2014","journal-title":"J\u00a0Surg Oncol"},{"issue":"4","key":"10.1016\/j.soc.2024.11.001_bib43","doi-asserted-by":"crossref","DOI":"10.1080\/02656730210123534","article-title":"Thermal enhancement of melphalan and oxaliplatin cytotoxicity in\u00a0vitro","volume":"18","author":"Urano","year":"2002","journal-title":"Int J Hyperther"},{"issue":"5","key":"10.1016\/j.soc.2024.11.001_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/S1470-2045(21)00134-0","article-title":"Limitations of the PRODIGE 7 trial","volume":"22","author":"Str\u00f6hlein","year":"2021","journal-title":"Lancet Oncol"},{"issue":"3","key":"10.1016\/j.soc.2024.11.001_bib45","doi-asserted-by":"crossref","DOI":"10.3390\/cancers16030631","article-title":"Recurrence and survival following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for synchronous and metachronous peritoneal metastases of colorectal origin","volume":"16","author":"Nielsen","year":"2024","journal-title":"Cancers (Basel)"},{"issue":"5","key":"10.1016\/j.soc.2024.11.001_bib46","doi-asserted-by":"crossref","DOI":"10.1245\/s10434-019-07218-w","article-title":"Repeat cytoreductive surgery-hyperthermic intraperitoneal chemoperfusion is feasible and offers survival benefit in select patients with peritoneal metastases","volume":"26","author":"Choudry","year":"2019","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.soc.2024.11.001_bib47","article-title":"Utility of perioperative measurement of cell-free DNA and circulating tumor DNA in informing the prognosis of GI cancers: a systematic review","volume":"6","author":"Hsu","year":"2022","journal-title":"JCO Precis Oncol"},{"key":"10.1016\/j.soc.2024.11.001_bib48","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.1093","article-title":"Evaluation of comparative surveillance strategies of circulating tumor DNA, imaging, and carcinoembryonic antigen levels in patients with resected colorectal cancer","author":"Fakih","year":"2022","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.soc.2024.11.001_bib49","doi-asserted-by":"crossref","DOI":"10.1177\/1758835920981351","article-title":"Liquid biopsy in peritoneal fluid and plasma as a prognostic factor in advanced colorectal and appendiceal tumors after complete cytoreduction and hyperthermic intraperitoneal chemotherapy","volume":"12","author":"L\u00f3pez-Rojo","year":"2020","journal-title":"Ther Adv Med Oncol"},{"issue":"1","key":"10.1016\/j.soc.2024.11.001_bib50","doi-asserted-by":"crossref","DOI":"10.1186\/s12885-022-09572-7","article-title":"GECOP-MMC: phase IV randomized clinical trial to evaluate the efficacy of hyperthermic intraperitoneal chemotherapy (HIPEC) with mytomicin-C after complete surgical cytoreduction in patients with colon cancer peritoneal metastases","volume":"22","author":"Pereira","year":"2022","journal-title":"BMC Cancer"},{"issue":"12","key":"10.1016\/j.soc.2024.11.001_bib51","article-title":"Safety and efficacy of oxaliplatin pressurized intraperitoneal aerosolized chemotherapy (PIPAC) in colorectal and appendiceal cancer with peritoneal metastases: results of a multicenter phase I trial in the USA","volume":"30","author":"Raoof","year":"2023","journal-title":"Ann Surg Oncol"}],"container-title":["Surgical Oncology Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1055320724000814?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1055320724000814?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,25]],"date-time":"2025-06-25T14:46:25Z","timestamp":1750862785000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1055320724000814"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":51,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["S1055320724000814"],"URL":"https:\/\/doi.org\/10.1016\/j.soc.2024.11.001","relation":{},"ISSN":["1055-3207"],"issn-type":[{"type":"print","value":"1055-3207"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment and Management of Peritoneal Spread from Colorectal Cancer Peritoneal Metastasis","name":"articletitle","label":"Article Title"},{"value":"Surgical Oncology Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.soc.2024.11.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}